In the 48 NPC cases positive for the expression of CXCR4, 95.8% also exhibited ETAR expression, and our experimental study also showed that ETAR activation increases functional CXCR4 expression in 6-10B and 5-8F NPC cells. The gene discussed is EDNRA; the disease is nasopharyngeal carcinoma.